This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 11 Jul 2016  |  Global  |  Technology Research

    Therapeutic Advances in Pain Management (TechVision)

     

    This research service covers key technological trends and developments across global analgesic products and technologies that are likely to have a high impact in the near future. Based on the observation of the global analgesic industry, advances and technological trends across existing and emerging technologies have been detailed. While providing ...

    $4,950.00
  2. 07 Jul 2016  |  Global  |  Technology Research

    Regenerative Medicine - The Future of Therapy (TechVision)

    After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerat...

    $4,950.00
  3. 30 Jun 2016  |  Global  |  Market Research

    Growth and Expansion of Regenerative Medicine Market

     

    The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments su...

    $1,500.00
  4. 30 Jun 2016  |  Global  |  Market Research

    Global Immunoglobulin Therapeutics Market

     

    Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...

    $1,500.00
  5. 30 Jun 2016  |  Global  |  Market Research

    Vital Signs The Analyst's Perspective - May 2016 Issue

    This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

    $450.00
  6. 27 Jun 2016  |  Global  |  Market Research

    Market Assessment of MRI Equipment and its Emerging Clinical Applications

    The global MRI market is currently experiencing steady growth (mid-single digit growth rate). Although economic uncertainty and budgetary constraints have slowed down the market in certain countries, technological innovation and extended/new clinical applications of MRI due to their high importance in the imaging space have enabled it to overcome t...

    $4,950.00
  7. 05 May 2016  |  Global  |  Market Research

    Future of Global Retail Healthcare Delivery Markets, Forecast to 2022

    Escalating Demand for Low-cost Alternatives to Create Market Size of Nearly $4 Billion

    Retail healthcare entails primary care services for minor illnesses provided through clinics located in retail environments, such as a pharmacies, grocery chains, supermarkets, or departmental stores. These retail care clinics, also called convenient care clinics, walk-in clinics, or in-store clinics, are often open beyond regular operating hours o...

    $3,000.00
  8. 29 Apr 2016  |  Global  |  Technology Research

    2016 Top Technologies in Medical Devices and Imaging (TechVision)

    High-impact Technologies Poised to Propel the Healthcare Industry

    TechVision's Medical Devices and Imaging technology cluster's latest research service profiles ten technologies that are expected to have a huge impact on the healthcare industry in the next two years. This report provides an overview of the ten technologies, and provides key pointers that are needed for strategic decision-making. Each of these tec...

    $4,950.00
  9. 29 Apr 2016  |  Global  |  Technology Research

    Health & Wellness Top 10 Technologies--2016 (TechVision)

    Top technology trends that are likely to have an impact in 2016

    This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in biosimilars, cancer screening, molecular scissors, next generation stem cells, three-dimensional (3D) scaffolds, therapeutic antibodies, cancer immunotherapy, high throug...

    $4,950.00
  10. 04 Apr 2016  |  Global  |  Market Research

    Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

    This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

    $450.00